TEVA 424B5: Secondary offering
Teva Pharmaceutical Finance entities
Filed with the SEC on · accession 0001193125-26-389382
TEVA filed a 424B5 (prospectus (offering)) with the SEC on Sep 11, 2026. The final terms of an offering of shares or bonds. The stock moved +2.0% by the first close after the filing.
Summary of the filing
Teva Pharmaceutical Finance entities issued €1.5 billion in Euro-denominated senior notes and $3.2 billion in USD-denominated senior notes across five tranches, guaranteed by Teva Pharmaceutical Industries, with total proceeds of approximately $4.9 billion equivalent.
Key details
How TEVA stock reacted
Close before
$36.35
Sep 10, 2026
First close after
+2.04%
$37.09
5 trading days
+7.81%
$39.19
Since filing
+17.22%
$42.61
✦ Ask GOAX AI about this filing — what it means for TEVA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TEVA?
Click hereFrequently asked questions
What did TEVA file with the SEC on Sep 11, 2026?
TEVA filed a 424B5 (Secondary offering). Teva Pharmaceutical Finance entities issued €1.5 billion in Euro-denominated senior notes and $3.2 billion in USD-denominated senior notes across five tranches, guaranteed by Teva Pharmaceutical Industries, with total proceeds of approximately $4.9 billion equivalent.
What does a secondary offering mean for TEVA stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did TEVA stock react to this filing?
TEVA closed at $36.35 before the filing and $37.09 on Sep 11, 2026 (+2.04%). Five trading days later: $39.19 (+7.81%).
Other TEVA SEC filings
- 10-Q · SEC filingNov 3, 2026
- 8-K · Guidance raiseNov 3, 2026
- SCHEDULE 13G/A · SEC filingNov 2, 2026
- 8-K · SEC filingOct 29, 2026
- 8-K · Material agreementSep 16, 2026
- 8-K · SEC filingSep 14, 2026
- 8-K · SEC filingSep 11, 2026
- 424B5 · Secondary offeringSep 8, 2026
- 8-K · SEC filingSep 3, 2026
- 8-K · SEC filingSep 3, 2026
Get alerts when TEVA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days